A promising HIV vaccine developed at Oregon Health & Science University is getting closer to human clinical trials.
Dr. Louis Picker, a professor at OHSU’s Vaccine & Gene Therapy Institute, said his lab has tested a weakened version of the vaccine in monkeys that provides similar protection to the original, stronger version.
Developing a weaker, or “live-attenuated,” version is important to ensure safety for people with weakened immune systems, Picker said.
